[applause] [cheering] [applause] I grew up around chronic illness. Not the kind that comes and goes, but the kind that lingers, defines dinner conversations and quietly shapes family's expectations. It seemed like everyone believed that illness was inevitable and that diagnosis was destiny and we didn't have the power to change it.But at the same time, I was training as an athlete. Every day, I was learning how to fuel, how to recover, how to push my limits and track progress. And I couldn't reconcile how o ...

Core Insights - Profusa, Inc. has made significant leadership additions, appointing Peter O'Rourke as lead independent director and Fred Knechtel as Chief Financial Officer, coinciding with its business combination with NorthView Acquisition Corp [1][2] - The company is positioned at a critical juncture as it prepares to launch its innovative biosensor platform into global markets, with leadership experience expected to drive growth and commercialization [2][3] Leadership Background - Peter O'Rourke has extensive experience in overseeing large healthcare systems, having managed over 1,300 facilities serving more than 9 million veterans during his tenure as Acting U.S. Secretary of Veterans Affairs [2][3] - Fred Knechtel brings a wealth of experience in finance and operations, having worked with various companies across multiple industries, including life sciences and automotive, guiding them through profitable growth and capital restructuring [3][4] Company Overview - Profusa is a digital health company focused on developing tissue-integrated sensors that provide continuous, actionable medical data, aiming to deliver personalized biochemical signatures for both personal and medical use [4] - The company emphasizes the affordability and long-lasting nature of its injectable biosensors, which are designed to be reliable for clinicians [4]